neuroprotective agents (CV Technologies)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameneuroprotective agents (CV Technologies)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine oxidase inhibitors
TargetsMonoamine oxidase
Therapy Area/IndicationsDepressionNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAfexa Life Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAfexa Life Sciences Inc
Active IndicationsN/A
Inactive IndicationsDepressionNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A